Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.67 USD | -1.01% | -0.87% | -24.52% |
Financials (USD)
Sales 2024 * | 1.54M | Sales 2025 * | 6.3M | Capitalization | 833M |
---|---|---|---|---|---|
Net income 2024 * | -208M | Net income 2025 * | -246M | EV / Sales 2024 * | 293 x |
Net cash position 2024 * | 380M | Net cash position 2025 * | 393M | EV / Sales 2025 * | 69.9 x |
P/E ratio 2024 * |
-4
x | P/E ratio 2025 * |
-3.63
x | Employees | 158 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.59% |
Latest transcript on Pliant Therapeutics, Inc.
1 day | -1.01% | ||
1 week | -0.87% | ||
Current month | +15.65% | ||
1 month | -3.39% | ||
3 months | -10.48% | ||
6 months | +6.38% | ||
Current year | -24.52% |
Managers | Title | Age | Since |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 16-01-31 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 21-01-11 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 16-06-30 |
Gayle Crowell
BRD | Director/Board Member | 73 | 20-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -.--% | ||
0.08% | 0 M€ | 0.00% | - | |
0.07% | 234 M€ | +2.60% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 13.67 | -1.01% | 392,239 |
24-05-10 | 13.81 | 0.00% | 487,214 |
24-05-09 | 13.81 | +2.98% | 417,228 |
24-05-08 | 13.41 | -2.76% | 222,543 |
24-05-07 | 13.79 | 0.00% | 322,966 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.52% | 833M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- PLRX Stock